LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 116 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $234,338 | +28.6% | 156,225 | +0.3% | 0.01% | +25.0% |
| Q4 2022 | $182,169 | -25.9% | 155,700 | -28.5% | 0.00% | -33.3% |
| Q3 2022 | $246,000 | -38.0% | 217,700 | -13.4% | 0.01% | -33.3% |
| Q2 2022 | $397,000 | +33.7% | 251,500 | +30.4% | 0.01% | +50.0% |
| Q1 2022 | $297,000 | -37.3% | 192,900 | -0.3% | 0.01% | -40.0% |
| Q4 2021 | $474,000 | +21.5% | 193,500 | +25.2% | 0.01% | +11.1% |
| Q3 2021 | $390,000 | – | 154,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 4,735,990 | $8,335,000 | 3.63% |
| BROADWOOD CAPITAL INC | 34,005,379 | $59,849,000 | 3.55% |
| Prescott General Partners LLC | 1,851,851 | $3,259,000 | 0.14% |
| Strategic Wealth Investment Group, LLC | 66,917 | $118,000 | 0.07% |
| Laidlaw Wealth Management LLC | 170,658 | $300,000 | 0.06% |
| Humankind Investments LLC | 26,737 | $47,000 | 0.05% |
| DAFNA Capital Management LLC | 80,000 | $141,000 | 0.04% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $79,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 680,839 | $1,198,000 | 0.02% |
| Allegheny Financial Group LTD | 20,000 | $35,000 | 0.02% |